EP 346 - We chat with the founder & CEO of Device Access - who help MedTech companies gain market access and regulatory approval - about how over regulation can stifle innovation and lead to an adverse impact on patient care and outcomes.Michael Branigan tells us about:Why US companies aren’t interested infringing their devices to the UK anymore (hint it’s cos we are tiny)Why regulation is stifling innovation, and how that is bad for all of us, but particularly the NHSHe also mentions Brexit, but not for the reasons that you’d expect.Chapters:00:00 BWB with Michael Branagan-Harris01:51 The Changing Landscape UK MedTech02:46 Impact of European Medical Device Regulations04:46 Challenges in the MedTech Industry05:55 Gov Initiatives and Their Shortcomings07:28 Understanding Medical Device Regulations14:42 The Role of NICE and Market Access28:56 The Future of MedTech and Market Strategies35:22 Affordability vs. Innovation in Healthcare37:00 Challenges in Medtech vs. Pharma37:39 Navigating the NHS Procurement Process38:59 Leveraging Data for Healthcare Solutions41:53 Global Perspectives on Healthcare Systems49:20 The Role of MedTech in Modern Healthcare52:12 Independent Clinical Evidence55:34 Quick Fire Round - Get to Know Michael01:00:06 Wrap Up and Advice for Entrepreneursbusinesswithoutbullshit.meWatch us on YouTubeFollow us:InstagramTikTokLinkedinTwitterIf you'd like to be on the show, get in contact - [email protected] is powered by Oury Clark

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related